Eri***PhD

Associate Director, Corporate Development

Bildung

Washington University School of Medicine in St. Louis

Washington University School of Medicine in St. Louis (2014 - 2019)

  • Degree: Doctor of Philosophy (PhD)
  • Field of Study: Division of Biology and Biomedical Sciences
  • Description:

The Ohio State University (2010 - 2014)

  • Degree: Bachelor of Science (B.S.)
  • Field of Study: Molecular Genetics
  • Description: Graduated with Honors Research Distinction in Molecular Genetics and Honors in the Arts and Sciences

Fähigkeiten:

PCR, qPCR, Research, Gel Electrophoresis

Berufserfahrung:

Associate Director, Corporate Development at Agios Pharmaceuticals

  • Location: New York, United States
  • Duration: 2024-02 to Present
  • Description:

Senior Manager, Corporate Development at Agios Pharmaceuticals

  • Location: New York, New York, United States
  • Duration: 2022-04 to 2024-02
  • Description:

Senior Associate at Charles River Associates

  • Location: New York, United States
  • Duration: 2022-03 to 2022-04
  • Description:

Consulting Associate at Charles River Associates

  • Location: Greater New York City Area
  • Duration: 2019-09 to 2022-02
  • Description: Serve as a strategic partner to healthcare organizations through: • Designing and executing market research studies that maximize client impact, from initial materials development through recommendation of key strategic and tactical insights • Performing early-stage product feasibility assessments, with a focus on unmet patient needs, scientific tractability, competitive landscapes, and product scalability • Designing and moderating interactive client working sessions, including product pipeline planning, loss of exclusivity planning, and competitive simulation workshops • Providing strategic and operational management to non-profit consortia of pharmaceutical experts to establish as go-to organizations for addressing pressing precompetitive issues

PhD Student/Graduate Researcher at Washington University School of Medicine

  • Location:
  • Duration: 2014-08 to 2019-07
  • Description: I performed my dissertation work in the lab of Dr. Hani Zaher. Broadly, I investigated the impact of mRNA structural alterations on translation. My primary project focused on elucidating the mechanism through which bacteria rescue ribosomes stalled on transcripts damaged via alkylation. Additionally, I worked to understand the structural preferences of the most common oxidative damage adduct, 8-oxoguanosine, in the context of the ribosome. My final project probed the role of the non-bridging oxygens of the mRNA phosphodiester backbone in tRNA selection.
KI-Lebenslaufanalyse

Kandidaten-Intelligenzbericht

KI-gestützte Analyse aus der Perspektive eines US-Einstellungsdirektors — Bewertung von Karrierekontinuität, Wachstumstrajektorie und Rollenpassung.

Karrierekontinuität und Risikobewertung

Employment GapLow

No significant employment gaps observed; minor transition periods (e.g., early career City changes) are typical and did not result in prolonged vacancies.

Industry ConsistencyLow

Career demonstrates a clear life sciences focus across academia, management consulting, and biotech corporate development, aligning with employer needs in pharma/biotech.

Tenure StabilityLow

Progression shows sustained tenure with promotions (CRA to Senior Associate; Agios promotions to Associate Director) and no long unexplained exits, indicating reliability and growth.

Education-Career MatchLow

PhD from a medical school combined with hands-on corporate development and consulting work provides strong scientific credibility and strategic business relevance for life sciences roles.

Karrierewachstumskurve

PhD Student/Graduate Researcher Entry
Washington University School of Medicine
2014-08 to 2019-07
Consulting Associate Entry
Charles River Associates
2019-09 to 2022-02
Senior Associate ↑ Befördert
Charles River Associates
2022-03 to 2022-04
Senior Manager ↑ Befördert
Agios Pharmaceuticals
2022-04 to 2024-02
Associate Director ↑ Befördert
Agios Pharmaceuticals
2024-02 to Present
Bewertung: Erica Thomas shows a steady upward trajectory with progressive leadership in corporate development and life sciences consulting. Her blend of scientific depth and strategic BD experience positions her well for senior leadership roles such as Senior Director or VP of Corporate Development; she may be a strong candidate for organizations seeking to scale partnerships and pipeline strategy.

Bestpassende Rollen (Top 5)

1

Senior Director, Corporate Development (Biotech/Pharma)95% Passung

Current trajectory and responsibilities align with senior leadership in corporate development, including pipeline planning, LOE strategy, and cross-functional leadership; track record supports strategic deal-making and portfolio optimization.

2

Vice President, Corporate Development (Biotech/Pharma)92% Passung

Proven progression to Associate Director with clear potential to lead a broader BD function, manage teams, and drive multi-year integration of strategy and execution.

3

Director, Corporate Strategy & Development (Life Sciences)85% Passung

Strong fit for roles that blend strategic planning, market analysis, and corporate development, leveraging consulting background and scientific acumen.

4

Principal, Life Sciences Strategy (Management Consulting)78% Passung

Leverages CRA experience and scientific depth; suitable for firms advising pharma/biotech clients on growth, portfolio strategy, and market entry.

5

Head of Strategic Partnerships (Life Sciences)72% Passung

Focus on external partnerships and alliances; aligns with her background in pipeline planning and competitive strategy, though may require broader external-facing leadership.

Erleben Sie AI Recruiter

Kostenlos starten. Lassen Sie Ihre Konkurrenten nicht den KI-Vorteil zuerst ergattern.

Schließen Sie sich über 10.000 Unternehmen an, die KI-gestützte Recruiting-Lösungen nutzen, um Ihren Einstellungsprozess zu automatisieren und 80% Zeitkosten zu sparen.

33% Rabatt, nur noch 48 Stunden!
Kostenlos AI testen

24/7 automatisierter Betrieb

KI-gestützte Kandidatenauswahl

Recruiting ohne geografische oder zeitliche Einschränkungen

Personalisierte intelligente Kommunikation

Automatisierte Bewertung des Kandidatenengagements

Ahmt Ihren Recruiting-Stil intelligent nach

4-monatige Geld-zurück-Garantie

Gewährleistet LinkedIn-Kontosicherheit